ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

RGT Argent Biopharma Limited

6.50
0.00 (0.00%)
Last Updated: 00:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Argent Biopharma Limited LSE:RGT London Ordinary Share AU0000326647 ORD NPV (DI)
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 6.50 5.00 8.00 6.50 6.50 6.50 1,516 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Holding(s) in Company

08/10/2003 3:55pm

UK Regulatory


RNS Number:6723Q
ReGen Therapeutics PLC
08 October 2003

ReGen Therapeutics Plc

8 October 2003

SUBSTANTIAL SHAREHOLDING

ReGen Therapeutics Plc (the "Company") announces that on 8 October 2003 it
received notification from Mr P. Garrod that he is beneficially interested in
24,000,000 ordinary shares of the Company representing 10.69% of the current
issued share capital of the Company.


For further information, please contact:

Andrew Marshall
Marshall Robinson Roe
Tel. 020 7960 6007


                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
HOLEALEPESLDFFE

1 Year Argent Biopharma Chart

1 Year Argent Biopharma Chart

1 Month Argent Biopharma Chart

1 Month Argent Biopharma Chart